BMJ ceases breastmilk substitute ads as firms' ties come under increased scrutiny

By Will Chu

- Last updated on GMT

©iStock/Juan Garcia Aunion
©iStock/Juan Garcia Aunion
The British Medical Journal (BMJ) is to stop carrying advertisements that feature breastmilk substitute products, costing the publication an estimated €350 000 (£300 000; $400 000) in 2020.

The decision is the latest in a growing backlash against infant formula firms and their relationships with publications, national health services, paediatricians and membership organisations.

Just last month, The Royal College of Paediatrics and Child Health (RCPCH) agreed to suspend future funding agreements​ with formula milk companies pending a College review.

Fiona Godlee, BMJ’s editor-in-chief referenced bodies such as the RCPCH in the journal’s decision adding, “The BMJ has been reminded of the substantial harms caused by promotion of breastmilk substitutes and the biases introduced into research and clinical practice by industry influence”.

“We have also gained a greater understanding of the WHO code that seeks to reduce these harms and have reviewed our policy, consulting advertisers and canvassing readers.”

“As a result, we have decided to stop carrying these advertisements in The BMJ and other BMJ journals, including Gut, Frontline Gastroenterology, and Archives of Diseases in Childhood, as soon as possible.

“We have chosen a complete ban because previous attempts to implement a due diligence approach have failed.” 

BSNA response

In an editorial, Godlee said the ban on product advertising was not a boycott of the companies adding that the journal would honour existing contracts for formula milk advertising. The final advert would appear later this year.

“Our objective is not to drive an anti-formula campaign, as we recognise that formula milks are essential products for children with complex medical or nutritional needs and for those women for whom breastfeeding is not possible.

“But decisions on when and how to use infant formula are best informed by sources of unbiased evidence rather than commercial advertisements.”

The BMJ’s decision was featured as part of a documentary​ on UK’s Channel 4, in which the programme claimed the €47bn (£40bn) infant formula industry was putting profit before babies.

The ‘Dispatches’ programme also revealed that since 2014 almost a third of 195 clinical commissioning groups in England had recorded a breach of the World Health Organisation guidance – such as a gift or sponsorship from a formula company.

However, The British Specialist Nutrition Association (BSNA), who represent the formula milk industry, accused the channel of “televising a very misleading episode, with many inaccuracies and assertions likely to unduly concern parents who, whether due to medical need or personal choice, feed their children infant formula”.

In a statement, the BSNA called for balanced reporting in important baby feeding debate adding, “As an industry, we also provide life-saving formulas without which some babies would not thrive, and in some cases not survive.

“We are a highly regulated industry and rightly so. The strict legal framework within which we operate sets standards for the composition and communication about baby milks.  It gives parents a high level of protection and is closely scrutinised. 

“Additionally, companies are only able to use European Food Safety (EFSA) approved claims on product labels. We would therefore urge any parent who has concerns about their specialised formula to speak to their healthcare professional before making any changes.”

The WHO code

The BSNA highlighted that whilst all formulas satisfied mandatory requirements, formulas differed due to additional ingredients led by scientific innovation.

“Our long history of research and innovation has led to significant improvements to infant formulas without which babies and parents would not benefit from the advanced formulas that are available today.

“We respect the role and integrity of clinicians and are committed to the principles and aims of the WHO Code, as set out in UK law. “

Current guidelines by the World Health Organisation (WHO) allow for companies and healthcare professionals to work together to conduct research and share scientific and factual information.  

The BDNA added the principles of its members’ engagement with healthcare professionals were fully transparent and were set out in the Infant Nutrition Industry (INI) Code.

“We believe that clinicians are well able to make good judgements about their relationship with industry of any type, within the framework of their own professional code of ethics.

“We share a common goal with healthcare professionals to ensure that all babies have access to the best nutrition.”

Related news

Show more

Related products

show more

Immune support for everyone

Immune support for everyone

Content provided by Kerry | 12-May-2023 | Infographic

Consumers of all ages cite immune health as a top benefit driving their purchases, along with improving gut/digestive health.

Living through the menopause comfortably

Living through the menopause comfortably

Content provided by Robertet Health & Beauty | 27-Apr-2023 | Product Brochure

Menopause is a natural event in a woman's life often perceived as a time characterized by gains and losses.

The experience is associated...

LIPOFER™: a bioavailable and stable source of iron

LIPOFER™: a bioavailable and stable source of iron

Content provided by Lipofoods, a Lubrizol Company | 26-Apr-2023 | White Paper

Maintaining adequate iron levels is critical to maintaining a healthy body, with deficiencies being the cause of several health issues including anemia...

Redefining Cognitive Health with Neumentix™

Redefining Cognitive Health with Neumentix™

Content provided by Kemin Human Nutrition and Health | 18-Apr-2023 | Product Brochure

Find out how Neumentix™, a naturally sourced ingredient grown from patented spearmint high in polyphenols, may nourish the mind.

Related suppliers

1 comment

Aluminium is the major issue of infant formulas

Posted by Professor Christopher Exley PhD FRSB,

Please see;

for the latest research on aluminium in infant formulas

Report abuse

Follow us


View more